Zimmer Biomet (ZBH) - Business Payback Period

Corporate emblem and logo of zimmerbiomet.com (ZBH)

Zimmer Biomet Holdings (ZBH) is optimizing product manufacturing through external contractors and the outsourcing of logistics. This accelerates the launch of new products, as evidenced by patents for complex systems and strict FDA oversight. The issuer's P/E ratio reflects the dynamics of return on capital, where the parameter has stabilized at 25.10. High switching costs and surgeon loyalty render the company's market positions virtually impregnable.

ZBH (Zimmer Biomet Holdings) P/E Multiple history from 07/04/2022 to 11/17/2026

Analytical breakdowns for zimmerbiomet.com (ZBH)

- stock quotes and analyst forecast:
Comprehensive company analysis:ZBH Zimmer Biomet Holdings Inc
Product sample of Zimmer Biomet Holdings

Fundamental risks for Zimmer Biomet Holdings (ZBH) are assessed through the ratio of market capitalization to net income. The complexity of implant production and stringent medical standards ensure the stability of the issuer's cash flows. A P/E valuation of the business allows for the filtering of emotional noise, demonstrating the real value of assets relative to their yield. The stable curve of this indicator confirms the maturity of the model, protecting investors from impulsive purchases at price peaks.

Key competitors

Price to Earnings Ratio BSX|Price to Earnings Ratio EW (Edwards Lifesciences Corporation)|Business Payback Period ResMed Inc.|P/E Multiple PODD (insulet.com)|COO (The Cooper Companies) - Market Cap to Net Income|ALGN: Price to Earnings Ratio|Market Cap to Net Income GMED|TMDX: P/E Multiple|Market Cap to Earnings ATEC Spine (ATEC)|AORT (Artivion) - P/E Multiple|Price to Earnings Multiple ENOV (Enovis)|Price to Earnings Ratio IART (Integra LifeSciences Holdings Corporation)|ESTA (Establishment Labs Corp) - Company Value to Net Income|Price to Earnings Ratio iLet Bionic Pancreas BBNX|IRMD - Price to Earnings Ratio|Embecta Corp - P/E Multiple|Market Cap to Earnings Tandem Diabetes Care|AXGN: P/E Multiple|Price to Earnings Multiple SIBN|OFIX (Orthofix Corp) - P/E Multiple|Price to Earnings Ratio Bioventus Corp (BVS)|P/E Multiple KIDS|Price to Earnings Ratio Treace Medical Concepts TMCI|P/E Multiple SRTA (blade.com)|P/E Multiple Carlsmed, Inc. CARL|RXST - Price to Earnings Ratio|CLPT: Price to Earnings Ratio|STXS (Stereotaxis, Inc.) - Price to Earnings Ratio|Neuronetics, Inc. - Company Value to Net Income|SGHT (Sight Sciences Inc) - P/E Multiple|Market Cap to Earnings Orchestra BioMed Inc. OBIO|Price to Earnings Ratio Anika Therapeutics, Inc. (ANIK)|InspireMD, Inc. (NSPR) - Market Cap to Net Income Ratio|Jin Medical International Ltd. - Price to Earnings Ratio|P/E Multiple Vivani VANI|Xtant Medical Holdings, Inc. - P/E Multiple|Business Payback Period NeuroOne NMTC|Modular Medical, Inc. (MODD) - Price to Earnings Ratio|Price to Earnings Ratio Myomo, Inc|Price to Earnings Ratio envoymedical.com|Price to Earnings Ratio Vivos Therapeutics (VVOS)|P/E Multiple NVNO|SINT - Market Cap to Earnings|Price to Earnings Ratio Tenon Medical, Inc. TNON|LFWD: Price to Earnings Multiple|AMIX: Price to Earnings Ratio|Business Payback Period invobioscience.com IVF|BBLG: P/E Multiple|Axonics Modulation Technologies (AXNX) - P/E Multiple|BIOL (Biolase Inc.) - P/E Multiple|Market Cap to Earnings dynatronics.com DYNT|P/E Multiple FNA|Price to Earnings Ratio INVO (INVO Bioscience Inc.)